Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35152 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Florian Janke und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Genome Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Head and Neck Neoplasms, DNA Copy Number Variations. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Krebshilfe.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Local recurrence after radiotherapy is common in locally advanced head and neck cancer (HNC) patients. Re‐irradiation can improve local disease control, but disease progression remains frequent. Hence, predictive biomarkers are needed to adapt treatment intensity to the patient's individual risk. We quantified circulating tumor DNA (ctDNA) in sequential plasma samples and correlated ctDNA levels with disease outcome. Ninety four longitudinal plasma samples from 16 locally advanced HNC patients and 57 healthy donors were collected at re‐radiotherapy baseline, after 5 and 10 radiation fractions, at irradiation end, and at routine follow‐up visits. Plasma DNA was subjected to low coverage whole genome sequencing for copy number variation (CNV) profiling to quantify ctDNA burden. CNV‐based ctDNA burden was detected in 8/16 patients and 25/94 plasma samples. Ten additional ctDNA‐positive samples were identified by tracking patient‐specific CNVs found in earlier sequential plasma samples. ctDNA‐positivity after 5 and 10 radiation fractions (both: log‐rank, p = .050) as well as at the end of irradiation correlated with short progression‐free survival (log‐rank, p = .006). Moreover, a pronounced decrease of ctDNA toward re‐radiotherapy termination was associated with worse treatment outcome (log‐rank, p = .005). Dynamic ctDNA tracking in serial plasma beyond re‐radiotherapy reflected treatment response and imminent disease progression. In five patients, molecular progression was detected prior to tumor progression based on clinical imaging. Our findings emphasize that quantifying ctDNA during re‐radiotherapy may contribute to disease monitoring and personalization of adjuvant treatment, follow‐up intervals, and dose prescription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Genome Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- German Center for Lung Research (DZL), TLRC Heidelberg, Heidelberg, Germany.
- National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Florian Janke
Förderung
- Deutsche Krebshilfe
Zitieren
APA
Janke, F., Stritzke, F., Dvornikovich, K., Franke, H., Angeles, A. K., Riediger, A. L., Ogrodnik, S., Gerhardt, S., Regnery, S., Schröter, P., Bauer, L., Weusthof, K., Görtz, M., Harrabi, S., Herfarth, K., Neelsen, C., Paech, D., Schlemmer, H. P., Abdollahi, A., …, & Held, T. (2025). Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy. International Journal of Cancer. https://doi.org/10.1002/ijc.35152
Vancouver
Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles AK, Riediger AL, et al. Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy. International Journal of Cancer. 2025. doi:10.1002/ijc.35152
BibTeX
@article{Janke2025,
author = {Janke, Florian and Stritzke, Florian and Dvornikovich, Katharina and Franke, Henrik and Angeles, Arlou Kristina and Riediger, Anja Lisa and Ogrodnik, Simon and Gerhardt, Sabrina and Regnery, Sebastian and Schröter, Philipp and Bauer, Lukas and Weusthof, Katharina and Görtz, Magdalena and Harrabi, Semi and Herfarth, Klaus and Neelsen, Christian and Paech, Daniel and Schlemmer, Heinz-Peter and Abdollahi, Amir and Adeberg, Sebastian and Debus, Jürgen and Sültmann, Holger and Held, Thomas},
title = {Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35152}
}
EUVIMED